These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32056667)

  • 41. In Vitro Reactivation of Replication-Competent and Infectious HIV-1 by Histone Deacetylase Inhibitors.
    Banga R; Procopio FA; Cavassini M; Perreau M
    J Virol; 2016 Feb; 90(4):1858-71. PubMed ID: 26656693
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modeling HIV-1 Latency Using Primary CD4
    Takata H; Kessing C; Sy A; Lima N; Sciumbata J; Mori L; Jones RB; Chomont N; Michael NL; Valente S; Trautmann L
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30918072
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Latent HIV-1 is activated by exosomes from cells infected with either replication-competent or defective HIV-1.
    Arenaccio C; Anticoli S; Manfredi F; Chiozzini C; Olivetta E; Federico M
    Retrovirology; 2015 Oct; 12():87. PubMed ID: 26502902
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of proximal biomarkers of PKC agonism and evaluation of their role in HIV reactivation.
    Vemula SV; Maxwell JW; Nefedov A; Wan BL; Steve J; Newhard W; Sanchez RI; Tellers D; Barnard RJ; Blair W; Hazuda D; Webber AL; Howell BJ
    Antiviral Res; 2017 Mar; 139():161-170. PubMed ID: 27889530
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients.
    Spivak AM; Bosque A; Balch AH; Smyth D; Martins L; Planelles V
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5984-91. PubMed ID: 26169416
    [TBL] [Abstract][Full Text] [Related]  

  • 46. BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency.
    Lu P; Shen Y; Yang H; Wang Y; Jiang Z; Yang X; Zhong Y; Pan H; Xu J; Lu H; Zhu H
    Sci Rep; 2017 Nov; 7(1):16646. PubMed ID: 29192216
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human immunodeficiency virus replication: modulation by cellular levels of cAMP.
    Nokta MA; Pollard RB
    AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1255-61. PubMed ID: 1381600
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Splicing Factor 3B Subunit 1 Interacts with HIV Tat and Plays a Role in Viral Transcription and Reactivation from Latency.
    Kyei GB; Meng S; Ramani R; Niu A; Lagisetti C; Webb TR; Ratner L
    mBio; 2018 Nov; 9(6):. PubMed ID: 30401776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of unrecognized host factors promoting HIV-1 latency.
    Li Z; Hajian C; Greene WC
    PLoS Pathog; 2020 Dec; 16(12):e1009055. PubMed ID: 33270809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Facts and fiction: cellular models for high throughput screening for HIV-1 reactivating drugs.
    Planelles V; Wolschendorf F; Kutsch O
    Curr HIV Res; 2011 Dec; 9(8):568-78. PubMed ID: 22211661
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibody-Mediated CD4 Depletion Induces Homeostatic CD4
    Kumar NA; McBrien JB; Carnathan DG; Mavigner M; Mattingly C; White ER; Viviano F; Bosinger SE; Chahroudi A; Silvestri G; Paiardini M; Vanderford TH
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30185596
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reactivation from latency displays HIV particle budding at plasma membrane, accompanying CD44 upregulation and recruitment.
    Suyama M; Daikoku E; Goto T; Sano K; Morikawa Y
    Retrovirology; 2009 Jul; 6():63. PubMed ID: 19594910
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reiterative Enrichment and Authentication of CRISPRi Targets (REACT) identifies the proteasome as a key contributor to HIV-1 latency.
    Li Z; Wu J; Chavez L; Hoh R; Deeks SG; Pillai SK; Zhou Q
    PLoS Pathog; 2019 Jan; 15(1):e1007498. PubMed ID: 30645648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dendritic cells maturated by co-culturing with HIV-1 latently infected Jurkat T cells or stimulating with AIDS-associated pathogens secrete TNF-α to reactivate HIV-1 from latency.
    Ren XX; Ma L; Sun WW; Kuang WD; Li TS; Jin X; Wang JH
    Virulence; 2017 Nov; 8(8):1732-1743. PubMed ID: 28762863
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of Latent HIV-1 T Cell Reservoirs with a Combination of Innate Immune and Epigenetic Regulators.
    Palermo E; Acchioni C; Di Carlo D; Zevini A; Muscolini M; Ferrari M; Castiello L; Virtuoso S; Borsetti A; Antonelli G; Turriziani O; Sgarbanti M; Hiscott J
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31413127
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of HIV-1 expression in latently infected CD4+ T cells by the small molecule PKC412.
    Ao Z; Zhu R; Tan X; Liu L; Chen L; Liu S; Yao X
    Virol J; 2016 Oct; 13(1):177. PubMed ID: 27769267
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of replication of reactivated human immunodeficiency virus type 1 (HIV-1) in latently infected U1 cells transduced with an HIV-1 long terminal repeat-driven PKR cDNA construct.
    Muto NF; Martinand-Mari C; Adelson ME; Suhadolnik RJ
    J Virol; 1999 Nov; 73(11):9021-8. PubMed ID: 10516008
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cleavage and Polyadenylation Specificity Factor 6 Is Required for Efficient HIV-1 Latency Reversal.
    Zheng Y; Schubert HL; Singh PK; Martins LJ; Engelman AN; D'Orso I; Hill CP; Planelles V
    mBio; 2021 Jun; 12(3):e0109821. PubMed ID: 34154414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel histone deacetylase inhibitor NCH-51 activates latent HIV-1 gene expression.
    Victoriano AF; Imai K; Togami H; Ueno T; Asamitsu K; Suzuki T; Miyata N; Ochiai K; Okamoto T
    FEBS Lett; 2011 Apr; 585(7):1103-11. PubMed ID: 21402072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.